XTL Biopharmaceuticals Ltd. - American Depositary Shares (XTLB) SEC filings
XTLB SEC filings moved a median of +2.77% by the close. XTLB SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the XTLB overview →
51 measured XTLB SEC filing events.
Where these XTLB SEC filings landedvs 49 measured XTLB SEC filing reactions
| Middle 50% of XTLB SEC filing reactions | -1.76% to +6.99% |
|---|---|
| Median reaction (to close) | +2.77% |
| Measured reactions | 49 |
Point-in-time · zero look-ahead
Half of the 49 XTLB SEC filing events with a measured close landed between -1.76% and +6.99%; 67% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 6-K XTL BIOPHARMACEUTICALS For: Oct 14 | SEC filing · Form 6-K | +0.54% | +2.69% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Aug 05 | SEC filing · Form 6-K | — | +3.98% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Jul 21 | SEC filing · Form 6-K | -4.93% | +2.82% | |
| Form 20-F XTL BIOPHARMACEUTICALS For: Dec 31 | SEC filing · Form 20-F | +0.62% | +3.32% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Jun 30 | SEC filing · Form 6-K | +0.62% | +3.32% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Jun 29 | SEC filing · Form 6-K | +1.57% | +7.48% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Jun 22 | SEC filing · Form 6-K | +1.17% | +8.56% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: May 22 | SEC filing · Form 6-K | +1.22% | -3.64% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: May 15 | SEC filing · Form 6-K | +1.93% | +4.36% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: May 07 | SEC filing · Form 6-K | -2.20% | -16.04% | |
| Form NT 20-F XTL BIOPHARMACEUTICALS For: Dec 31 | SEC filing · Form NT | -2.04% | -7.13% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Apr 29 | SEC filing · Form 6-K | -6.67% | -6.81% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Mar 20 | SEC filing · Form 6-K | -1.17% | -2.40% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Mar 10 | SEC filing · Form 6-K | -4.70% | +1.53% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Feb 27 | SEC filing · Form 6-K | +6.47% | +16.75% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Feb 24 | SEC filing · Form 6-K | — | +3.13% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Feb 23 | SEC filing · Form 6-K | -8.96% | +4.02% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Feb 17 | SEC filing · Form 6-K | -2.59% | +12.42% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Jan 28 | SEC filing · Form 6-K | +1.84% | +2.60% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Jan 23 | SEC filing · Form 6-K | -4.57% | -9.22% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Jan 13 | SEC filing · Form 6-K | -9.17% | +23.41% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Dec 30 | SEC filing · Form 6-K | — | +2.81% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Dec 29 | SEC filing · Form 6-K | +0.00% | -4.66% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Dec 12 | SEC filing · Form 6-K | +1.12% | -4.77% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Dec 05 | SEC filing · Form 6-K | — | +2.79% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Oct 22 | SEC filing · Form 6-K | +0.00% | +0.00% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Jul 28 | SEC filing · Form 6-K | +1.19% | — | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Jul 21 | SEC filing · Form 6-K | — | +3.41% | |
| Form 6-K/A XTL BIOPHARMACEUTICALS For: Jun 18 | SEC filing · Form 6-K | — | -17.35% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Jun 13 | SEC filing · Form 6-K | +1.79% | +8.93% | |
| Form 20-F XTL BIOPHARMACEUTICALS For: Dec 31 | SEC filing · Form 20-F | +9.09% | +6.99% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Apr 07 | SEC filing · Form 6-K | -1.63% | -8.54% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Mar 04 | SEC filing · Form 6-K | -11.26% | -9.06% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Feb 03 | SEC filing · Form 6-K | — | -1.76% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Dec 30 | SEC filing · Form 6-K | +0.02% | +9.50% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Nov 19 | SEC filing · Form 6-K | — | +0.00% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Nov 12 | SEC filing · Form 6-K | — | +5.06% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Oct 15 | SEC filing · Form 6-K | +0.45% | -10.76% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Aug 14 | SEC filing · Form 6-K | +0.00% | +1.52% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Jul 22 | SEC filing · Form 6-K | +0.00% | -1.47% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Jun 11 | SEC filing · Form 6-K | +0.93% | +0.69% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Jun 05 | SEC filing · Form 6-K | +0.40% | +0.40% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: May 13 | SEC filing · Form 6-K | +2.78% | +1.74% | |
| Form 20-F XTL BIOPHARMACEUTICALS For: Dec 31 | SEC filing · Form 20-F | — | +1.55% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Apr 30 | SEC filing · Form 6-K | +0.00% | +2.77% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Apr 02 | SEC filing · Form 6-K | +0.54% | +20.65% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Mar 21 | SEC filing · Form 6-K | +7.79% | +7.38% | |
| Form 6-K/A XTL BIOPHARMACEUTICALS For: Mar 21 | SEC filing · Form 6-K | +7.79% | +7.38% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Mar 20 | SEC filing · Form 6-K | +9.61% | +89.04% | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Nov 15 | SEC filing · Form 6-K | — | — | |
| Form 6-K XTL BIOPHARMACEUTICALS For: Oct 20 | SEC filing · Form 6-K | — | +17.27% |
Keep exploring
More XTLB: earnings → · analyst actions → · XTLB overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| BIOASIS TECHNOLOGIES INC (BIOAF) | 73 | 0.00% | 20% |
| CHARLOTTES WEB HLDGS INC (CWBHF) | 73 | +1.18% | 53% |
| ARRAYIT CORP (ARYC) | 71 | -1.05% | 36% |
| Aeterna Zentaris Inc. (AEZS) | 70 | +0.61% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.